Shuttle Pharmaceuticals Holdings, Inc. (SHPH) EPS by Year
SHPH
Shuttle Pharmaceuticals Holdings, Inc. lost $7.16 per diluted share in fiscal year 2025. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Shuttle Pharmaceuticals Holdings, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)-$7.16
Source SEC Filings (10-K/10-Q)Latest period Q1 FY2026, ended Mar 31, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
SHPH EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
More Shuttle Pharmaceuticals Holdings, Inc. financials
What was Shuttle Pharmaceuticals Holdings, Inc.'s diluted earnings per share in fiscal year 2025?
Shuttle Pharmaceuticals Holdings, Inc. lost $7.16 per diluted share in fiscal year 2025.
What was Shuttle Pharmaceuticals Holdings, Inc.'s diluted earnings per share in the most recent quarter?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported -$0.43 in diluted earnings per share in Q1 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Shuttle Pharmaceuticals Holdings, Inc. (SHPH) reported on that line in every period on record.
